SMS Lifesciences P/E Ratio

SMSLIFE • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
22.27
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 22.27
Current Price ₹1353.50
EPS (TTM) ₹66.51
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 9.08
Historical Range 6.93 - 12.65
Percentile 100.0%

Sector Context

Sector Average 47.67
Sector Median 25.75
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹58.57
Mar 2025 ₹9.83
Jun 2025 ₹13.75

Key P/E Ratio Insights for SMS Lifesciences

  • Current PE is 145.1% above historical average
  • Trading at discount to sector average PE of 47.67

P/E Ratio Historical Trend for SMS Lifesciences

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 6.93 76.22 ₹528.15 NSE Low
2022 12.65 58.23 ₹736.40 NSE Low
2021 8.79 70.33 ₹618.40 NSE Low
2020 7.97 33.29 ₹265.35 NSE Low

Sector P/E Ratio Comparison

Comparing SMS Lifesciences with other companies in Healthcare sector
Sector Average
47.67
Sector Median
25.75
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low